Funded Programmes

THE LATEST FUNDING NEWS IN Norway

To view all of the programmes being funded by the Movember Foundation, please see our Report Cards section. (English only)


Prostate Cancer Breakthrough, November 2014

Research funded by the Movember Foundation has resulted in a scientific breakthrough with significant implications for men with prostate cancer. The research project, led by Professor Robert Bristow in Toronto, Canada, has found that men have a genetic “signature” that will identify prostate cancer patients who are at high risk of their cancer returning after primary treatment, such as surgery or radiotherapy. A new test will allow men to be offered a more personalised treatment plan, avoid unnecessary treatments and side effects, and will increase chances of survival.

The team was funded primarily by the Movember Foundation with a grant of CAD $15 million, which is largest donation we have made to a single research project. The findings have been published this month in the Lancet, one of the world’s leading medical journals, and the research team will now work with institutions across the globe to validate the test over the next 2-3 years.

  • Click here to watch the video of Professor Robert Bristow (English only).
  • Click here to learn more about prostate cancer

Funds in Action: Professor Kristin Taksén

Here, Movember funded researcher Professor Kristin Taksén explains how her work is making a difference here in Norway.



Read all about it: Movember’s global action plan news

By bringing together more than 250 of the world's top prostate and testicular cancer researchers, the Global Action Plan (GAP) facilitates a new and unprecedented level of global research collaboration, not previously seen within the cancer community.



Norwegian Cancer Society

At a national level Movember partners with the Norwegian Cancer Society, which is the country's leading not for profit organisation addressing the challenges of cancer. The organisation is focused on research funding, cancer care, cancer prevention, information provision and international collaboration.